DKK898.80
0.92% today
Copenhagen, Nov 26, 02:46 pm CET
ISIN
DK0060448595
Symbol
COLO B
Sector

Coloplast A/S B Target price 2024 - Analyst rating & recommendation

Coloplast A/S B Classifications & Recommendation:

Buy
30%
Hold
52%
Sell
19%

Coloplast A/S B Price Target

Target Price DKK920.91
Price DKK890.60
Potential
Number of Estimates 23
23 Analysts have issued a price target Coloplast A/S B 2025 . The average Coloplast A/S B target price is DKK920.91. This is higher than the current stock price. The highest price target is
DKK1,030.00 15.65%
register free of charge
, the lowest is
DKK700.00 21.40%
register free of charge
.
A rating was issued by 27 analysts: 8 Analysts recommend Coloplast A/S B to buy, 14 to hold and 5 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Coloplast A/S B stock has an average upside potential 2025 of . Most analysts recommend the Coloplast A/S B stock at Hold.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Sep '24 2025
Estimates
Revenue Billion DKK 27.03 29.31
10.33% 8.42%
EBITDA Margin 32.19% 32.54%
0.35% 1.10%
Net Margin 18.72% 19.72%
8.34% 5.32%

24 Analysts have issued a sales forecast Coloplast A/S B 2025 . The average Coloplast A/S B sales estimate is

DKK29.3b
Unlock
. This is
8.42% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
DKK29.5b 9.27%
Unlock
, the lowest is
DKK29.0b 7.24%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 DKK27.0b 10.33%
2025
DKK29.3b 8.42%
Unlock
2026
DKK31.8b 8.57%
Unlock
2027
DKK34.6b 8.83%
Unlock
2028
DKK38.0b 9.80%
Unlock
2029
DKK40.6b 6.90%
Unlock

23 Analysts have issued an Coloplast A/S B EBITDA forecast 2025. The average Coloplast A/S B EBITDA estimate is

DKK9.5b
Unlock
. This is
9.64% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
DKK10.0b 14.65%
Unlock
, the lowest is
DKK9.2b 5.52%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 DKK8.7b 10.72%
2025
DKK9.5b 9.61%
Unlock
2026
DKK10.6b 11.57%
Unlock
2027
DKK11.8b 11.20%
Unlock
2028
DKK13.3b 12.32%
Unlock
2029
DKK14.5b 9.25%
Unlock

EBITDA Margin

2024 32.19% 0.35%
2025
32.54% 1.10%
Unlock
2026
33.44% 2.77%
Unlock
2027
34.17% 2.18%
Unlock
2028
34.95% 2.28%
Unlock
2029
35.72% 2.20%
Unlock

19 Coloplast A/S B Analysts have issued a net profit forecast 2025. The average Coloplast A/S B net profit estimate is

DKK5.8b
Unlock
. This is
13.34% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
DKK6.5b 27.26%
Unlock
, the lowest is
DKK5.6b 10.16%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 DKK5.1b 1.13%
2025
DKK5.8b 14.19%
Unlock
2026
DKK6.7b 15.37%
Unlock
2027
DKK7.6b 13.79%
Unlock
2028
DKK8.8b 16.24%
Unlock
2029
DKK9.5b 7.73%
Unlock

Net Margin

2024 18.72% 8.34%
2025
19.72% 5.32%
Unlock
2026
20.96% 6.29%
Unlock
2027
21.91% 4.53%
Unlock
2028
23.19% 5.84%
Unlock
2029
23.37% 0.78%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Sep '24 2025
Estimates
Earnings Per Share DKK 22.46 25.65
1.13% 14.20%
P/E 34.72
EV/Sales 7.59

19 Analysts have issued a Coloplast A/S B forecast for earnings per share. The average Coloplast A/S B <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

DKK25.65
Unlock
. This is
13.35% higher
Unlock
than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
DKK28.80 27.26%
Unlock
, the lowest is
DKK24.93 10.16%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 DKK22.46 1.13%
2025
DKK25.65 14.20%
Unlock
2026
DKK29.59 15.36%
Unlock
2027
DKK33.67 13.79%
Unlock
2028
DKK39.14 16.25%
Unlock
2029
DKK42.16 7.72%
Unlock

P/E ratio

Current 39.36 13.01%
2025
34.72 11.79%
Unlock
2026
30.10 13.31%
Unlock
2027
26.45 12.13%
Unlock
2028
22.76 13.95%
Unlock
2029
21.12 7.21%
Unlock

Based on analysts' sales estimates for 2025, the Coloplast A/S B stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 8.23 4.18%
2025
7.59 7.74%
Unlock
2026
6.99 7.90%
Unlock
2027
6.43 8.11%
Unlock
2028
5.85 8.93%
Unlock
2029
5.47 6.45%
Unlock

P/S ratio

Current 7.42 3.96%
2025
6.85 7.77%
Unlock
2026
6.31 7.90%
Unlock
2027
5.80 8.11%
Unlock
2028
5.28 8.93%
Unlock
2029
4.94 6.45%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today